Hey guys, long term of observer of this thread and first time contributor. The benefit of reading Lollies' comments and everyone else's replies is to see questions being posed about the business which are then explained by subsequent responses, which so far to me look like reasonable answers. It's always good to have someone test your convictions - as long as they are legitimate queries. I personally hold and believe the company has a solid chance to be something of real value. Whether that happens will depend on a lot of things, but the springboard is there. End of the day it's a spec buy. But once upon a time A2M was also a spec buy and was also viewed by many as over valued at $1. Thanks to everyone who has been posting on this thread - it's been great to learn from.
- Forums
- ASX - By Stock
- NZS
- 4c fair value ($30M), 8c short term target ($60M)
4c fair value ($30M), 8c short term target ($60M), page-1841
Featured News
Add NZS (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.334M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
NZS (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online